Another Justice Department Web site with a cute name is hanging on to misinformation about the American Medical Association’s position on medical marijuana.
From JustThinkTwice.org:
The American Medical Association has rejected pleas to endorse marijuana as medicine, and instead has urged that marijuana remain a prohibited, Schedule I drug, at least until more research is done.
It's false, and it needs to change. Please join me in sending an e-mail to AskDOJ@usdoj.gov and asking them to update this language.
Also of note is the relative silence from the drug czar’s office. You would think the Office of National Drug Control Policy would have something to say about a new marijuana position from the nation's largest medical association, right? Wouldn't that warrant a press release or blog post? It certainly has whenever the AMA said something negative about marijuana.
I guess they’re showing their true colors. The drug czar’s office isn’t about bringing you up-to-date, factual information on drugs and drug policy. Their job is to make sure you don’t question the laws we have in place -- even when it puts them at odds with reality. So when the nation's largest group of doctors breaks from the government talking points, all we hear is silence.
For some time we’ve been pointing out the massive pile of evidence that THC and other cannabinoids have potential as anticancer drugs. A new study out of Thailand demonstrates that THC can fight cholangiocarcinoma – cancer of the bile duct. This is a rare but deadly form of cancer, with only 30 percent of patients still alive after five years, according to the Cholangiocarcinoma Foundation. Based on these new lab results, the Thai researchers conclude, “THC is potentially used to retard cholangiocarcinoma cell growth and metastasis.”
We’ve been updating readers this week about the American Medical Association’s new position on marijuana and the DEA’s response. Last night, the DEA removed a number of AMA-related talking points from its Web site. This may seem like a very small, almost meaningless step, but it’s important to remember how influential the AMA really is.
Striking this language from the DEA’s Web site is a manifestation of something larger and more abstract: the gutting of our opponents’ most effective talking point.
I know everyone reading this blog has sent a letter to their member of Congress and asked for medical marijuana reforms (If you haven’t, you can here), and I’m willing to bet a lot of you have received negative responses. Think back to that response … did it mention the AMA’s opposition? Chances are it did.
When marijuana prohibition was first debated in 1937, one of the first questions was “What is the AMA’s position?” This line of thinking has been pervasive ever since. In every state where MPP has fought for patients, in every congressional office in Washington, and in countless media debates, prohibitionists have used the AMA’s opposition as their flagship talking point. That they can no longer do so is a major development.
Tonight, after a week of calls by activists, the Drug Enforcement Administration updated its Web site to reflect the American Medical Association’s recent call for a review of marijuana’s Schedule I status.
The update removed several references to the AMA, including: “the American Medical Association recommends that marijuana remain a Schedule I controlled substance,” and “the American Medical Association has rejected pleas to endorse marijuana as medicine.” These changes came just over a week after the AMA released its new position on marijuana.
When it comes to marijuana’s status as a Schedule I drug, there is now a battle between cops and doctors. The cops say it has no medical value, but the doctors -- who one might think are in a position to know -- either say it does or, at a minimum, want the government to review its stance. And again, medical marijuana advocates are left wondering why the cops have a say in this debate at all. It will be interesting to see how the DEA does characterize the AMA's new position. MPP will let you know when they do.
AMA, DEA, Schedule I
When it comes to medical marijuana dispensaries and their right to exist under California state law, Los Angeles County District Attorney Steve Cooley doesn’t seem to want to listen.
Earlier this year, Cooley ignored the legal opinion of California’s attorney general when Cooley claimed (incorrectly) that virtually all medical marijuana dispensaries were operating illegally and should be shut down.
Now, after two L.A. City Council committees rejected calls to ban the sale of medical marijuana, Cooley is once again making up his own rules, declaring that he will prosecute dispensaries even if the city council adopts an ordinance allowing the legal sale of medical marijuana under state law.
Perhaps someone should remind the district attorney that he is paid to uphold the law, not invent it.
The battle in L.A. is not over yet, but two City Council committees have rejected draconian and bad advice from City Attorney Carmen Trutanich, the Los Angeles Times reports.
Last week’s announcement from the American Medical Association -- calling for a federal review of marijuana's legal status -- has been well received in the media, reaching the pages of The Washington Post, LA Times, and other publications. One group that hasn’t got the message is the Drug Enforcement Administration. This is no surprise, as the DEA has been ignoring recommendations to research marijuana’s medical benefits for decades.
But this example is particularly egregious. On the DEA Web page “Exposing the Myth of Smoked Medical Marijuana,” the agency writes, “the American Medical Association recommends that marijuana remain a Schedule I controlled substance.” That statement directly contradicts the new policy that the AMA issued last week.
The DEA also has a contact page where you can call them out on this (likely) willful ignorance of recent news: http://www.justice.gov/dea/contactinfo.htm
AMA, DEA, Schedule I
There’s a fantastic article in today’s Los Angeles Times about the successful regulation of medical marijuana dispensaries in West Hollywood, where city leaders, neighbors and even school officials have learned to embrace the shops and their patients as part of the greater community:
In West Hollywood, city officials say, it's been more than two years since a resident has complained about a dispensary. Neighborhood watch leaders say their streets are safer because the dispensary guards are required to walk nearby blocks. School officials welcome dispensaries as neighbors. And the L.A. County Sheriff's Department, which patrols the city, says there have been no recent crimes at dispensaries and no calls from agitated neighbors.
As the article goes on to explain, this positive model provides a stark contrast to cities such as Los Angeles and San Diego that do not have regulations, and consequently have witnessed more tension between community members and existing dispensaries.
In case anyone needs proof of the mass media’s tendency to repeat government pronouncements without bothering to check their accuracy, here’s a small but telling example:
Inexplicably, when the U.S. Department of Justice issued a memo last month explaining that it would generally refrain from prosecuting medical marijuana activities that are clearly legal under state law, it mistakenly indicated that there are 14 medical marijuana states. DOJ’s goof was to include Maryland, where medical marijuana is not actually legal, but where state law provides for reduced penalties to patients who successfully present a medical-necessity defense.
DOJ’s goof has now traveled though most of the known universe, repeated by credulous news media. The Associated Press, after talking to MPP, at least included an explanatory note about the discrepancy, but others just repeated the mistake with no explanation, including Katie Couric of CBS, the Washington Post, Voice of America, the Guardian of London, and even the editorial page of the New York Times.
C’mon, guys, tell me that fact-checking isn’t entirely dead. Kudos to those media outlets that got it right, including CNN.
In its official response to the AMA’s recent call for a review of marijuana’s status as a Schedule I drug (barring any medical use) under federal law, the White House Office of National Drug Control Policy stated that it would defer to "the FDA's judgment that the raw marijuana plant cannot meet the standards for identity, strength, quality, purity, packaging and labeling required of medicine."
While we’re not used to factual accuracy from ONDCP, in this case they’re wrong not once, but twice.
First, there is absolutely no reason that plant medicines can’t be standardized and controlled for purity and potency. Indeed, the Netherlands has been doing just that for years, with medical marijuana distributed in Dutch pharmacies that is “of pharmaceutical quality and complies with the strictest requirements,” according to the Dutch government.
Second, the FDA has never said that a natural plant product can’t be a medicine. Indeed the agency has a lengthy “Guidance for Industry: Botanical Drug Products,” specifically designed to aid developers of plant medicines. The document not only doesn’t rule out plants as medicines, it even states, “In the initial stage of clinical studies of a botanical drug, it is generally not necessary to identify the active constituents or other biological markers or to have a chemical identification and assay for a particular constituent or marker.” Given that the active components of marijuana are already well-known and extensively researched, marijuana is well ahead of where the FDA says plant products need to be to start the process of seeking FDA licensing.
Yes, the FDA did put out a press release in 2006 saying that “smoked marijuana” had not been shown to be a safe and effective medicine. That statement was utterly unscientific, as we pointed out at the time, but it was absolutely not a declaration that the plant could never be a medicine.